Literature DB >> 1907615

Activation of human monocyte--derived macrophages with lipopolysaccharide decreases human immunodeficiency virus replication in vitro at the level of gene expression.

M S Bernstein1, S E Tong-Starksen, R M Locksley.   

Abstract

Activation of T lymphocytes infected with the human immunodeficiency virus-1 (HIV-1) results in enhancement of viral replication mediated in part by activation of cellular NF kappa B capable of binding directly to sequences in the viral long terminal repeat, or LTR. Together with CD4+ T cells, macrophages constitute a major target for infection by HIV-1. Unlike lymphocytes, however, stimulation of mononuclear phagocytes is not associated with cell division and proliferation. Human monocyte-derived macrophages transfected with HIV-LTR-CAT constructs demonstrated down-regulation of CAT activity after stimulation with bacterial lipopolysaccharide (LPS) that mapped to a region distinct from NF kappa B binding sites. In contrast, fresh monocytes and the promonocytic U937 cell line both demonstrated up-regulation of HIV-LTR-CAT expression by LPS. Differentiation of U937 by PMA to establish a nondividing phenotype resulted in down-regulation of transfected HIV-LTR-CAT activity by LPS similar to that in mature macrophages. Human monocyte-derived macrophages infected with HIV-1 in vitro demonstrated a decrease in viral p24 release after incubation in LPS that was comparable to the negative regulation that occurred in the transient transfection assays. Factors controlling HIV replication may differ in dividing and nondividing hematopoietic cells and may contribute to restricted viral expression in nondividing cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1907615      PMCID: PMC295381          DOI: 10.1172/JCI115337

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  43 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Signaling through T lymphocyte surface proteins, TCR/CD3 and CD28, activates the HIV-1 long terminal repeat.

Authors:  S E Tong-Starkesen; P A Luciw; B M Peterlin
Journal:  J Immunol       Date:  1989-01-15       Impact factor: 5.422

Review 3.  Regulatory pathways governing HIV-1 replication.

Authors:  B R Cullen; W C Greene
Journal:  Cell       Date:  1989-08-11       Impact factor: 41.582

4.  Infection of monocyte/macrophages by human T lymphotropic virus type III.

Authors:  D D Ho; T R Rota; M S Hirsch
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

5.  Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone.

Authors:  T M Folks; K A Clouse; J Justement; A Rabson; E Duh; J H Kehrl; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

6.  The same 50-kDa cellular protein binds to the negative regulatory elements of the interleukin 2 receptor alpha-chain gene and the human immunodeficiency virus type 1 long terminal repeat.

Authors:  M R Smith; W C Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

7.  Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B.

Authors:  L Osborn; S Kunkel; G J Nabel
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

8.  Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat.

Authors:  E J Duh; W J Maury; T M Folks; A S Fauci; A B Rabson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

9.  NF-kappa B-mediated activation of the human immunodeficiency virus enhancer: site of transcriptional initiation is independent of the TATA box.

Authors:  A Bielinska; S Krasnow; G J Nabel
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

10.  Lipopolysaccharide is a potent monocyte/macrophage-specific stimulator of human immunodeficiency virus type 1 expression.

Authors:  R J Pomerantz; M B Feinberg; D Trono; D Baltimore
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

View more
  28 in total

1.  The synthetic immunomodulator murabutide controls human immunodeficiency virus type 1 replication at multiple levels in macrophages and dendritic cells.

Authors:  E C Darcissac; M J Truong; J Dewulf; Y Mouton; A Capron; G M Bahr
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Differential inhibition of human immunodeficiency virus type 1 in peripheral blood mononuclear cells and TZM-bl cells by endotoxin-mediated chemokine and gamma interferon production.

Authors:  Anthony R Geonnotti; Miroslawa Bilska; Xing Yuan; Christina Ochsenbauer; Tara G Edmonds; John C Kappes; Hua-Xin Liao; Barton F Haynes; David C Montefiori
Journal:  AIDS Res Hum Retroviruses       Date:  2010-03       Impact factor: 2.205

3.  Transcriptional activation of HIV by Mycobacterium tuberculosis in human monocytes.

Authors:  Z Toossi; L Xia; M Wu; A Salvekar
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

4.  Lipopolysaccharide and phorbol 12-myristate 13-acetate both impair monocyte differentiation, relating cellular function to virus susceptibility.

Authors:  S Basta; S Knoetig; A Summerfield; K C McCullough
Journal:  Immunology       Date:  2001-08       Impact factor: 7.397

5.  Release of human immunodeficiency virus by THP-1 cells and human macrophages is regulated by cellular adherence and activation.

Authors:  R J Shattock; J S Friedland; G E Griffin
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

Review 6.  Tuberculosis and HIV disease: two decades of a dual epidemic.

Authors:  Muktar H Aliyu; Hamisu M Salihu
Journal:  Wien Klin Wochenschr       Date:  2003-10-31       Impact factor: 1.704

Review 7.  Host hindrance to HIV-1 replication in monocytes and macrophages.

Authors:  Anna Bergamaschi; Gianfranco Pancino
Journal:  Retrovirology       Date:  2010-04-07       Impact factor: 4.602

8.  Exposure to bacterial products renders macrophages highly susceptible to T-tropic HIV-1.

Authors:  M Moriuchi; H Moriuchi; W Turner; A S Fauci
Journal:  J Clin Invest       Date:  1998-10-15       Impact factor: 14.808

Review 9.  Oral infectious diseases: a potential risk factor for HIV virus recrudescence?

Authors:  O A González; J L Ebersole; C B Huang
Journal:  Oral Dis       Date:  2009-04-02       Impact factor: 3.511

Review 10.  Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage.

Authors:  Evelyn M Kilareski; Sonia Shah; Michael R Nonnemacher; Brian Wigdahl
Journal:  Retrovirology       Date:  2009-12-23       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.